Pure Global AI
MS / MINEFID Arrêté

Arrêté conjoint n°2020-156/MS/MINEFID

Arrêté conjoint portant autorisation de perception de recettes et tarification des prestations de l’ANRP
Burkina FasoMinistère de la Santé et Ministère de l’Économie, des Finances et du DéveloppementRegistrationCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

Arrêté conjoint n°2020-156/MS/MINEFID is the official MS / MINEFID identifier for “Arrêté conjoint portant autorisation de perception de recettes et tarification des prestations de l’ANRP”. Arrêté conjoint n°2020-156/MS/MINEFID is the official identifier MS / MINEFID uses for this instrument.

Instrument
Arrêté
Full name
Arrêté conjoint n°2020-156/MS/MINEFID
Category
Registration
Source links
Source publication
French
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Arrêté conjoint portant autorisation de perception de recettes et tarification des prestations de l’ANRP

Joint ministerial order signed 19 May 2020; Article 7 applies from signature. The Ministry of Health and Ministry of Economy, Finance and Development are the joint issuers; ANRP is the service beneficiary and source host. Page 4 rows 13–15 cover medical consumables and rows 16–18 laboratory reagents, with first authorization, major variation (100%), minor variation (10%) and renewal (50%) columns. No per-product or per-dossier unit is inferred for those rows, and laboratory reagents are not all presumed IVDs. General medical equipment is not expressly covered. Page 8 contains conditional import visa/special import fees and exceptions. Device/IVD applicability of clinical-trial rows is not established by this order alone. Article 5 permits tariff changes by Board deliberation; the missing 2021-0023 complementary-fees text and later amendments prevent a current-tariff claim.

Arrêté conjoint n°2020-156/MS/MINEFID is the official identifier MS / MINEFID uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.